Innate Pharma (IPHA) Shareholder's Equity (2017 - 2025)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shareholder's Equity (Qtr)
1 Quantum Biopharma 1,638,563.89 Bn 1,638,563.89 Bn - 595,226.00
2 Alterity Therapeutics 767,934.24 Bn 767,934.20 Bn - -
3 Legend Biotech 2,937.00 Bn 2,936.10 Bn 242.10 Mn -
4 Nanobiotix 2,226.01 Bn 2,225.95 Bn - -
5 Akari Therapeutics 2,169.69 Bn 2,169.69 Bn - 14.38 Mn
6 Vertex Pharmaceuticals 110.41 Bn 103.16 Bn 2.59 Bn 19.36 Bn
7 Regeneron Pharmaceuticals 66.44 Bn 57.69 Bn 3.31 Bn 31.42 Bn
8 Evaxion A 65.44 Bn 65.42 Bn - -
9 Alnylam Pharmaceuticals 39.53 Bn 36.52 Bn 959.66 Mn 1.08 Bn
10 Innate Pharma 199.64 Mn 199.64 Mn - -25.26 Mn

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 -25.26 Mn
Jun 30, 2025 5.82 Mn
Dec 31, 2024 9.44 Mn
Jun 30, 2024 31.01 Mn
Dec 31, 2023 55.84 Mn
Jun 30, 2023 63.01 Mn
Dec 31, 2022 55.25 Mn
Jun 30, 2022 124.13 Mn
Dec 31, 2021 122.91 Mn
Jun 30, 2021 160.84 Mn
Dec 31, 2020 185.97 Mn
Jun 30, 2020 207.76 Bn
Dec 31, 2019 240.66 Mn
Dec 31, 2018 190.89 Mn
Dec 31, 2017 101.21 Mn